Cargando…
Oligonucleotides Targeting Telomeres and Telomerase in Cancer
Telomeres and telomerase have become attractive targets for the development of anticancer therapeutics due to their involvement in cancer cell immortality. Currently, several therapeutics have been developed that directly target telomerase and telomeres, such as telomerase inhibitors and G-quadruple...
Autores principales: | Schrank, Zachary, Khan, Nabiha, Osude, Chike, Singh, Sanjana, Miller, Rachel J., Merrick, Collin, Mabel, Alexander, Kuckovic, Adijan, Puri, Neelu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225148/ https://www.ncbi.nlm.nih.gov/pubmed/30189661 http://dx.doi.org/10.3390/molecules23092267 |
Ejemplares similares
-
Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance
por: Schrank, Zachary, et al.
Publicado: (2018) -
Treating Cancer by Targeting Telomeres and Telomerase
por: Ivancich, Marko, et al.
Publicado: (2017) -
Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy
por: Eckburg, Adam, et al.
Publicado: (2020) -
Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung Cancer
por: Osude, Chike, et al.
Publicado: (2022) -
Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma
por: Pitman, Ryan T, et al.
Publicado: (2013)